BİOTREND ÇEVRE VE ENERJİ YATIRIMLARI A.Ş.

Transaction in Own Shares • Apr 30, 2025

Summary Info	Share Buy-Back Programme Approved at the General Assembly dated 02.04.2025
Update Notification Flag	No
Correction Notification Flag	No
Postponed Notification Flag	No

Company Performs the Buy-Back	BİOTREND ÇEVRE VE ENERJİ YATIRIMLARI A.Ş.
Company Subject to Buy-Back	BİOTREND ÇEVRE VE ENERJİ YATIRIMLARI A.Ş.

Type Of Buy-Back	Within The Frame Of Buy-Back Program
Board Decision Date	11.03.2025
If Any, Duration Of Buy-Back Program	1 Year
Total Amount Of The Fund Set Aside For Acqusition	100.000.000

Scheduled Period Of Buy-Back

Code of Share Subject to Buy-back	Starting Date Of Period	Ending Date Of Period	Nominal Value (TRY)	Ratio To Capital (%)
BIOEN, TREBION00012	02.04.2025	02.04.2026

Additional Explanations

This disclosure has been prepared in order to send the Share Buyback Programme which announced on 12.03.2025 from the correct template.

At the Board of Directors meeting of our Company dated 11.03.2025, the following decision was taken for initiate a new share buyback programme by our Company in accordance with the Capital Markets Board Communiqué No. II-22. 1 numbered Buy-Back Shares Communiqué of the Capital Markets Board;

(i) To submit the attached "Biotrend Çevre ve Enerji Yatırımları Anonim Şirketi Share Buy-Back Programme" prepared by our Board of Directors in order to protect the interests of the shareholders of the Company and to contribute to the formation of a healthy and stable price in the Company's share market for the approval of the General Assembly at the Ordinary General Assembly Meeting to be held on 02 April 2025,

(ii) To determine the maximum fund as TL 100. 000.000 and that the fund shall be met from the Company's own resources and the income generated from its activities,

(iii) The duration of the buy-back programme shall be determined as maximum 1 (one) year from the date of approval of the Programme by the General Assembly of the Company.

The buy-back programme was submitted to the approval of the shareholders at the Ordinary General Assembly Meeting held on 02.04.2025 and was approved.

The English translation of this disclosure is attached hereto and in case of any discrepancy in the text of the disclosure, the Turkish version of shall prevail.

Supplementary Documents

Appendix: 1	Biotrend - Pay Geri Alım Programı .pdf - Buy-Back Program
Appendix: 2	Biotrend Share Buy Back Programme.pdf - Buy-Back Program